Aurinia Pharmaceuticals Set to Reveal Q2 Earnings: A Deep Dive Analysis
🌥️Introduction: As the biopharmaceutical industry continues to shape the future of healthcare, investors eagerly await the upcoming earnings call from [...]
Aurinia Pharmaceuticals Intrinsic Value Calculation – Cantor Fitzgerald Forecasts Aurinia Pharmaceuticals to Post FY2024 Earnings of Per Share
☀️Trending News Cantor Fitzgerald is bullish on the prospects of Aurinia Pharmaceuticals ($NASDAQ:AUPH) Inc. and is forecasting that the company [...]
BCV Decreases Investment in Aurinia Pharmaceuticals
🌥️Trending News Recently, Defense World reported that Banque Cantonale Vaudoise has decreased its ownership in Aurinia Pharmaceuticals ($NASDAQ:AUPH) Inc. (AUP). [...]
Aurinia Pharmaceuticals Experiences Oversold Status
🌥️Trending News Aurinia Pharmaceuticals ($NASDAQ:AUPH) (NASDAQ: AUPH) has recently experienced an oversold status. Aurinia Pharmaceuticals is a clinical-stage biopharmaceutical company [...]
Aurinia Pharmaceuticals Intrinsic Value Calculation – Aurinia Pharmaceuticals Continues to Make a Mark with Lupkynis Sales
🌥️Trending News Aurinia Pharmaceuticals ($NASDAQ:AUPH) is continuing to make its mark in the pharmaceutical industry with the continued success of [...]
Aurinia Shareholder Vote Mild, But Sale Bid Not Completely Out of the Picture
Trending News 🌥️ Aurinia Pharmaceuticals ($NASDAQ:AUPH) is a publicly traded biopharmaceutical company that specializes in the development of innovative therapies [...]
Aurinia Pharmaceuticals Shares Surge After Board Member Resignations Amid Shareholder Vote
Trending News 🌥️ Aurinia Pharmaceuticals ($NASDAQ:AUPH), a Canadian biopharmaceutical company, has seen its shares surge after two of its board [...]
Aurinia Pharmaceuticals Reports Positive Quarterly Results, Beating Revenue and EPS Estimates
Trending News ☀️ Aurinia Pharmaceuticals ($NASDAQ:AUPH) recently reported highly positive quarterly results, surpassing both revenue and earnings per share (EPS) [...]
Gladstone Institutional Advisory LLC Cashes Out 33300 Shares of Aurinia Pharmaceuticals
Trending News ☀️ Aurinia Pharmaceuticals ($NASDAQ:AUPH) Inc. (AUPH) recently experienced an institutional investor sale, as Gladstone Institutional Advisory LLC chose [...]
Aurinia Pharmaceuticals Stock Fair Value Calculator – Aurinia Pharmaceuticals Reports Positive 18-Month Lupkynis Kidney Biopsy Results
Trending News ☀️ Aurinia Pharmaceuticals ($NASDAQ:AUPH) is a biopharmaceutical company dedicated to developing innovative treatments for serious diseases. Recently, Aurinia [...]
